These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 31918259)
1. Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas. Escoll M; Lastra D; Pajares M; Robledinos-Antón N; Rojo AI; Fernández-Ginés R; Mendiola M; Martínez-Marín V; Esteban I; López-Larrubia P; Gargini R; Cuadrado A Redox Biol; 2020 Feb; 30():101425. PubMed ID: 31918259 [TBL] [Abstract][Full Text] [Related]
2. Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma. Rodríguez-Núñez P; Romero-Pérez L; Amaral AT; Puerto-Camacho P; Jordán C; Marcilla D; Grünewald TG; Alonso J; de Alava E; Díaz-Martín J J Pathol; 2020 Apr; 250(4):374-386. PubMed ID: 31880317 [TBL] [Abstract][Full Text] [Related]
3. Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma. Ahmad F; Dixit D; Sharma V; Kumar A; Joshi SD; Sarkar C; Sen E Cell Death Dis; 2016 May; 7(5):e2213. PubMed ID: 27148686 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway. Zhu G; Wang Y; Mijiti M; Wang Z; Wu PF; Jiafu D Biochem Biophys Res Commun; 2015 Sep; 465(2):194-9. PubMed ID: 26241672 [TBL] [Abstract][Full Text] [Related]
5. ERK and PI3K signaling cascades induce Nrf2 activation and regulate cell viability partly through Nrf2 in human glioblastoma cells. Cong ZX; Wang HD; Wang JW; Zhou Y; Pan H; Zhang DD; Zhu L Oncol Rep; 2013 Aug; 30(2):715-22. PubMed ID: 23708697 [TBL] [Abstract][Full Text] [Related]
6. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer. Li Z; Wang Y; Zhu Y; Yuan C; Wang D; Zhang W; Qi B; Qiu J; Song X; Ye J; Wu H; Jiang H; Liu L; Zhang Y; Song LN; Yang J; Cheng J Mol Oncol; 2015 Jun; 9(6):1091-105. PubMed ID: 25704916 [TBL] [Abstract][Full Text] [Related]
7. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ). Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of NF-E2-related factor 2 inhibits the proliferation and growth of U251MG human glioma cells in a mouse xenograft model. Ji XJ; Chen SH; Zhu L; Pan H; Zhou Y; Li W; You WC; Gao CC; Zhu JH; Jiang K; Wang HD Oncol Rep; 2013 Jul; 30(1):157-64. PubMed ID: 23673813 [TBL] [Abstract][Full Text] [Related]
9. The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma. Li J; Li Z; Wu Y; Wang Y; Wang D; Zhang W; Yuan H; Ye J; Song X; Yang J; Jiang H; Cheng J Cell Death Dis; 2019 Aug; 10(8):603. PubMed ID: 31399556 [TBL] [Abstract][Full Text] [Related]
10. Cbx7 is epigenetically silenced in glioblastoma and inhibits cell migration by targeting YAP/TAZ-dependent transcription. Nawaz Z; Patil V; Arora A; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K Sci Rep; 2016 Jun; 6():27753. PubMed ID: 27291091 [TBL] [Abstract][Full Text] [Related]
11. Paraspeckle Protein NONO Promotes TAZ Phase Separation in the Nucleus to Drive the Oncogenic Transcriptional Program. Wei Y; Luo H; Yee PP; Zhang L; Liu Z; Zheng H; Zhang L; Anderson B; Tang M; Huang S; Li W Adv Sci (Weinh); 2021 Dec; 8(24):e2102653. PubMed ID: 34716691 [TBL] [Abstract][Full Text] [Related]
12. PIN1 facilitates ubiquitin-mediated degradation of serine/threonine kinase 3 and promotes melanoma development via TAZ activation. Kim G; Bhattarai PY; Lim SC; Kim JY; Choi HS Cancer Lett; 2021 Feb; 499():164-174. PubMed ID: 33253791 [TBL] [Abstract][Full Text] [Related]
13. RNA splicing factor USP39 promotes glioma progression by inducing TAZ mRNA maturation. Ding K; Ji J; Zhang X; Huang B; Chen A; Zhang D; Li X; Wang X; Wang J Oncogene; 2019 Sep; 38(37):6414-6428. PubMed ID: 31332287 [TBL] [Abstract][Full Text] [Related]
14. TAZ activation by Hippo pathway dysregulation induces cytokine gene expression and promotes mesothelial cell transformation. Matsushita A; Sato T; Mukai S; Fujishita T; Mishiro-Sato E; Okuda M; Aoki M; Hasegawa Y; Sekido Y Oncogene; 2019 Mar; 38(11):1966-1978. PubMed ID: 30401981 [TBL] [Abstract][Full Text] [Related]
15. The role of transcriptional coactivator TAZ in gliomas. Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783 [TBL] [Abstract][Full Text] [Related]
16. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor. Valencia-Sama I; Zhao Y; Lai D; Janse van Rensburg HJ; Hao Y; Yang X J Biol Chem; 2015 Jul; 290(27):16906-17. PubMed ID: 25995450 [TBL] [Abstract][Full Text] [Related]
17. MiRNA-125a-5p inhibits glioblastoma cell proliferation and promotes cell differentiation by targeting TAZ. Yuan J; Xiao G; Peng G; Liu D; Wang Z; Liao Y; Liu Q; Wu M; Yuan X Biochem Biophys Res Commun; 2015 Feb; 457(2):171-6. PubMed ID: 25542152 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896 [TBL] [Abstract][Full Text] [Related]
20. RLIP76 is overexpressed in human glioblastomas and is required for proliferation, tumorigenesis and suppression of apoptosis. Wang Q; Wang JY; Zhang XP; Lv ZW; Fu D; Lu YC; Hu GH; Luo C; Chen JX Carcinogenesis; 2013 Apr; 34(4):916-26. PubMed ID: 23276796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]